BIZ NEWSHEALTH CARE & PHARMAINDUSTRIESLIFE SCIENCESTECH FOR SOCIALTRENDING

Flash Glucose Monitoring System to Revolutionize Diabetes Management in India

• Glucose assessment tool from Abbott will empower doctors to help their patients manage their diabetes effectively
• Software presents data in a user-friendly, visual chart, enabling productive treatment discussions
• India is the first country globally to launch this technology*

MUMBAI, 1 April 2015 –If you have diabetes or know of someone who does, you know the importance of living your life normally with vitality and achieving the important goal of preventing long term complications of diabetes.

Abbott today launched the professional version of its Flash Glucose Monitoring System, a transformative glucose monitoring technology for people with diabetes. The Flash Glucose Monitoring System is a glucose assessment tool that fundamentally changes how doctors can personalize their patient’s diabetes treatment plans thus allowing patients to better manage their disease.

“India now carries 20 percent of the global burden of diabetes,” said Robert Ford, senior vice president, Diabetes Care, Abbott. “There is an immense need to help people in India better manage their diabetes, enabling them to live healthier lives. Abbott’s Flash Glucose Monitoring System is designed to empower doctors in India to help their patients through rich data and actionable insights.”

Abbott′s Flash Glucose Monitoring System consists of a small, round sensor— slightly larger than a 10 rupee coin. A doctor applies the discreet, water-resistant1 and disposable sensor on the back of the upper arm of a person with diabetes. The sensor is held in place with a self-adhesive pad and remains on the back of the arm for up to 14 days, requiring no patient interaction with the sensor or finger-prick calibration.

The system continuously measures glucose in interstitial fluid through a small (5mm long, 0.4mm wide) filament that is inserted just under the skin. It records glucose levels every 15 minutes, capturing up to 1340 glucose readings over 14 days, thus giving the treating doctor comprehensive data for a complete glucose profile of their patient.

After 14 days, the person returns to the doctor’s office, where the doctor uses a Flash Glucose Monitoring reader to scan the sensor and download the glucose results that are stored in the sensor—in as quickly as five seconds. Scanning can take place while the sensor is under clothing2, making scanning more discreet and convenient.

The Importance of Visual Data

Once the reader has downloaded the glucose data from the sensor, the doctor then transfers the data from the reader into a computer. The software can generate reports that provide doctors with the Ambulatory Glucose Profile (AGP) graph, a visual snapshot, which helps them:

  • Clearly and easily understand when sugar levels go high and low (hypoglycemic 3 or hyperglycemic 4 ) over a typical 24 hour period
  • Identify when patient presents hypoglycemic or hyperglycemic trends
  • Detect overnight hypoglycemia trends
  • Identify postprandial (sugar levels after taking food) glucose spikes

This data can help doctors have more productive discussions with their patients, make more informed treatment decisions and modify treatment accordingly to suit a patient’s individual lifestyle. These reports can also be used as an information tool by people with diabetes to see the impact of food, medication, health and exercise on their blood sugar levels thus empowering the patient to taking control of their diabetes.

“There is a significantly high number of people with diabetes in India who have poor sugar control despite everything that they do to control it,” said Dr. Shashank Joshi, a leading Endocrinologist and Diabetologist and President, Association of Physicians of India. “Current diabetes monitoring tools are limiting since they do not reveal a complete picture of the glucose fluctuations that a person goes through during a day. The reports from Abbott’s Flash Glucose Monitoring System provide me with a complete glucose profile that will help me to make more informed treatment decisions, which in turn will help my patients to better manage their diabetes.”

“Abbott is at the forefront of healthcare innovation, helping people live healthier,” said Dilip Rajan, Country Head of Abbott’s diabetes care unit in India. “Customer insights on the shortcomings associated with current monitoring tools guided the development of the Flash Glucose Monitoring System. This technology will assist doctors manage diabetes of their patients better. We are excited that India is the first country globally to launch the professional version of the flash glucose monitoring technology.”

Diabetes in India

India’s population living with diabetes today is 65.1 million, and that number is expected to cross 100 million by 2030 5. Poor diabetes control, a factor that has been observed in the Indian population with diabetes, puts them at increased risk of health complications including nerve problems, heart diseases, retinopathy and foot ulcers 6.

The recent Abbott Sugar Survey conducted in partnership with the Association of Physicians of India 7 showed that 90% of people surveyed with uncontrolled diabetes [higher than 7 HbA1c] in India continue to perceive that they have control over their glucose levels, despite facts suggesting otherwise. Managing diabetes effectively is following a healthy meal plan, exercising regularly, taking medicines regularly as advised and monitoring glucose levels 8.

The Flash Glucose Monitoring System will be available to doctors in Mumbai, Delhi, Chennai, Bangalore, Pune and Trivandrum in the coming weeks.

For further details, call the Abbott Diabetes toll-free customer care number at 0008001005780 or write to us at [email protected]

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 73,000 people.

In India, Abbott has more than 14,000 employees working in manufacturing, research and development, logistics, sales and marketing and is headquartered in Mumbai.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

———————————————————————————-

The facts in this release were not verified by Digital Creed.

Brian Pereira

Brian Pereira is an Indian journalist and editor based in Mumbai. He is Editor-in-Chief of Digital Creed, which he founded in 2015. A technology buff, former computer instructor, and software developer, Brian has 27 years of journalism experience (since 1994). He is sound and confident about his knowledge of business technology concepts. And he is a believer in continual education/learning. Brian is the former Editor of CHIP and InformationWeek magazines (India). He has written hundreds of technology articles for India's leading newspaper groups such as The Times of India and Indian Express Newspapers (among others). And he has conducted more than 300 industry interviews during his journalism career. Brian also writes on Aviation, cybersecurity, startups, and topics directed at small and medium businesses. He achieved certifications from the EC-Council (Certified Secure Computer User) and from IBM (Basics of Cloud Computing). Apart from those, he has successfully completed many courses on Content Marketing and Business Writing. Follow Brian on Twitter (@creed_digital) and LinkedIn.

Related Articles

Leave a Reply

Back to top button